Altamira Therapeutics Ltd.
USD0.30
+0.30 (+100.00%)
CEO
Thomas Meyer
IPO Date
2014-08-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
BM
Open
$0.30
Prev. Close
$0.30
Day Low
$0.30
Day High
$0.30
52W Low
$0.30
52W High
$0.42
Market Cap
$0.00B
Volume
0.72M
| 31 Dec 2022 | FY | -372.4% | -8680.2% | 319.0% | -420.9% | -0.76 | 0.14 | -0.2 |
| 31 Dec 2021 | FY | -3407.3% | -26703.1% | -130.9% | -90.6% | 0.04 | 0.84 | -1.3 |
| 31 Dec 2020 | FY | 100.0% | -4699.8% | -48.9% | -39.4% | 0.03 | 3.83 | -1.7 |
| 31 Dec 2019 | FY | 100.0% | 11842.9% | -109.9% | -71.9% | 0.00 | 1.04 | -1.4 |
| 31 Dec 2018 | FY | 100.0% | -908.1% | -315.0% | -116.4% | 0.39 | 1.33 | -1.2 |
| 31 Dec 2017 | FY | 100.0% | -7580.4% | 1128.9% | -136.9% | -4.68 | 1.52 | -2.2 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -216.8% | -86.0% | 0.87 | 3.76 | -2.4 |
| 31 Dec 2015 | FY | 100.0% | 44335.8% | -66.4% | -56.2% | 0.00 | 8.28 | -10.6 |
| 31 Dec 2023 |
| Q4 |
| 0.0% |
| 0.0% |
| 0.0% |
| 0.0% |
| 0.02 |
| 1.38 |
| 0.0 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 1.38 | 0.0 |
| 30 Jun 2023 | Q2 | -101.2% | -5140.8% | 148.6% | -43.7% | -1.90 | 0.32 | -0.2 |
| 31 Mar 2023 | Q1 | -101.2% | -5140.8% | 148.6% | -43.7% | -1.84 | 0.32 | -0.5 |
| 31 Dec 2022 | Q4 | 73.7% | -169.3% | 9.6% | -12.7% | -0.76 | 0.14 | -7.7 |
| 30 Sept 2022 | Q3 | 127.5% | 2093.9% | 115.6% | -152.5% | -0.75 | 0.14 | -0.1 |
| 30 Jun 2022 | Q2 | -310.2% | -2832.9% | -53.7% | -22.3% | 0.68 | 0.20 | -0.4 |
| 31 Mar 2022 | Q1 | -310.2% | -2832.9% | -61.1% | -22.3% | 0.76 | 0.20 | -1.0 |